Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers

doi:10.5306/wjco.v2.i3.158

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3310)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

375

HTML

2774

Figures (1-1)

161

Sum=3310

Mar 10, 2011 (publication date) through Jun 10, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Mar 10, 2011; 2(3): 158-163
Published online Mar 10, 2011. doi: 10.5306/wjco.v2.i3.158

Full Size Figure Download Figure

Figure 1 Signal transmission in the epidermal growth factor receptor pathways. RAS/RAF/MAPK and PI3K/AKT/mTOR cascades are major pathways downstream of the epidermal growth factor receptor (EGFR). ¹Inhibition sites by molecular-targeted drugs.

Citation: Tada M, Nakai Y, Sasaki T, Hamada T, Nagano R, Mohri D, Miyabayashi K, Yamamoto K, Kogure H, Kawakubo K, Ito Y, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Isayama H, Omata M, Koike K. Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers. World J Clin Oncol 2011; 2(3): 158-163
URL: https://www.wjgnet.com/2218-4333/full/v2/i3/158.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i3.158